A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

NCT05355701 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

267

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma
Non-Small-Cell Lung Cancer
Thyroid Cancer
Glioma
Advanced Colorectal Cancer (Part 1)

Interventions

DRUG: PF-07799933
DRUG: binimetinib
BIOLOGICAL: cetuximab
DRUG: midazolam
DRUG: fluorouracil
DRUG: leucovorin
DRUG: oxaliplatin

Sponsor

Pfizer